Julius W. Kim

1.1k total citations
22 papers, 853 citations indexed

About

Julius W. Kim is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Julius W. Kim has authored 22 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Genetics and 12 papers in Oncology. Recurrent topics in Julius W. Kim's work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (9 papers) and RNA Interference and Gene Delivery (9 papers). Julius W. Kim is often cited by papers focused on Virus-based gene therapy research (14 papers), CAR-T cell therapy research (9 papers) and RNA Interference and Gene Delivery (9 papers). Julius W. Kim collaborates with scholars based in United States, Australia and Japan. Julius W. Kim's co-authors include Maciej S. Lesniak, Lingjiao Zhang, Jian Qiao, Yu Han, Alan L. Chang, Mahua Dey, Derek A. Wainwright, Irina V. Balyasnikova, Chung Kwon Kim and Alex L. Tobias and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Julius W. Kim

22 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julius W. Kim United States 14 448 335 288 280 163 22 853
Ekaterina Friebel Switzerland 8 358 0.8× 594 1.8× 231 0.8× 272 1.0× 69 0.4× 11 987
Katarzyna C. Pituch United States 13 414 0.9× 597 1.8× 316 1.1× 328 1.2× 63 0.4× 16 1.1k
Sadhak Sengupta United States 14 396 0.9× 387 1.2× 244 0.8× 278 1.0× 121 0.7× 26 820
Lukas Bunse Germany 15 372 0.8× 322 1.0× 318 1.1× 224 0.8× 20 0.1× 44 778
Stacy A. Decker United States 9 293 0.7× 377 1.1× 164 0.6× 191 0.7× 50 0.3× 10 766
Yuedi Wang China 8 280 0.6× 300 0.9× 91 0.3× 196 0.7× 32 0.2× 10 573
Hikmat Assi United States 12 251 0.6× 367 1.1× 136 0.5× 294 1.1× 151 0.9× 17 763
Nasser K. Yaghi United States 10 368 0.8× 317 0.9× 353 1.2× 388 1.4× 68 0.4× 24 965
Roeltje R. Maas Switzerland 8 364 0.8× 557 1.7× 316 1.1× 272 1.0× 18 0.1× 12 955
Haipeng Tao United States 5 350 0.8× 193 0.6× 76 0.3× 132 0.5× 79 0.5× 10 488

Countries citing papers authored by Julius W. Kim

Since Specialization
Citations

This map shows the geographic impact of Julius W. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julius W. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julius W. Kim more than expected).

Fields of papers citing papers by Julius W. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julius W. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julius W. Kim. The network helps show where Julius W. Kim may publish in the future.

Co-authorship network of co-authors of Julius W. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Julius W. Kim. A scholar is included among the top collaborators of Julius W. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julius W. Kim. Julius W. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rashidi, Aida, Jason Miska, Catalina Lee-Chang, et al.. (2019). GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma. Cancer Immunology Immunotherapy. 69(1). 81–94. 40 indexed citations
2.
Kong, Benjamin Y., Holly A. Bolton, Julius W. Kim, et al.. (2019). On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy. Frontiers in Oncology. 9. 50–50. 12 indexed citations
3.
Kim, Julius W., J. Robert Kane, Wojciech K. Panek, et al.. (2018). A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics. 15(4). 1127–1138. 21 indexed citations
4.
Panek, Wojciech K., Katarzyna C. Pituch, Jason Miska, et al.. (2018). Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model. Molecular Neurobiology. 56(7). 5032–5040. 18 indexed citations
5.
Kim, Julius W., Alan L. Chang, J. Robert Kane, et al.. (2018). Gene Therapy and Virotherapy of Gliomas. Progress in neurological surgery. 32. 112–123. 10 indexed citations
6.
Kim, Julius W., Jason Miska, Jacob S. Young, et al.. (2017). A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model. Molecular Therapy — Oncolytics. 5. 97–104. 16 indexed citations
7.
Rashidi, Aida, Jason Miska, Katarzyna C. Pituch, et al.. (2017). IMMU-06. GCN2 KINASE IS ESSENTIAL FOR ADAPTIVE T-CELL IMMUNITY IN GLIOMA. Neuro-Oncology. 19(suppl_6). vi113–vi113. 1 indexed citations
8.
Kanojia, Deepak, Ramin A. Morshed, Lingjiao Zhang, et al.. (2015). βIII-Tubulin Regulates Breast Cancer Metastases to the Brain. Molecular Cancer Therapeutics. 14(5). 1152–1161. 42 indexed citations
9.
Kanojia, Deepak, Irina V. Balyasnikova, Ramin A. Morshed, et al.. (2015). Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases. Stem Cells. 33(10). 2985–2994. 32 indexed citations
10.
Qiao, Jian, Mahua Dey, Alan L. Chang, et al.. (2015). Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy. OncoImmunology. 4(8). e1022302–e1022302. 27 indexed citations
11.
Kim, Julius W., Ramin A. Morshed, J. Robert Kane, et al.. (2015). Viral Vector Production: Adenovirus. Methods in molecular biology. 1382. 115–130. 4 indexed citations
12.
Kane, J. Robert, Jason Miska, Jacob S. Young, et al.. (2015). Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro-Oncology. 17(suppl 2). ii24–ii36. 58 indexed citations
13.
Kim, Julius W., Jacob S. Young, Elena Solomaha, et al.. (2015). A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors. Scientific Reports. 5(1). 18133–18133. 13 indexed citations
14.
Kim, Julius W., J. Robert Kane, Jacob S. Young, et al.. (2015). A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma. Human Gene Therapy. 26(9). 635–646. 11 indexed citations
15.
Spencer, Drew, Jacob S. Young, Deepak Kanojia, et al.. (2015). Unlocking the Promise of Oncolytic Virotherapy in Glioma: Combination With Chemotherapy to Enhance Efficacy. Therapeutic Delivery. 6(4). 453–468. 10 indexed citations
16.
Kim, Julius W., Jacob S. Young, Maciej S. Lesniak, & Irina V. Balyasnikova. (2015). 22. A Novel Single-Chain Antibody for Selective Targeting of IL13Ra2-Expressing Brain Tumors. Molecular Therapy. 23. S10–S10. 2 indexed citations
17.
Wainwright, Derek A., Alan L. Chang, Mahua Dey, et al.. (2014). Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors. Clinical Cancer Research. 20(20). 5290–5301. 448 indexed citations
18.
Young, Jacob S., Julius W. Kim, Atique U. Ahmed, & Maciej S. Lesniak. (2014). Therapeutic cell carriers: a potential road to cure glioma. Expert Review of Neurotherapeutics. 14(6). 651–660. 19 indexed citations
19.
Young, Jacob S., Ramin A. Morshed, Julius W. Kim, et al.. (2014). Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy. Expert Opinion on Drug Delivery. 11(11). 1733–1746. 21 indexed citations
20.
Kim, Julius W., et al.. (2013). An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer. PLoS ONE. 8(2). e55533–e55533. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ekaterina Friebel Breakdown of academic impact, for papers by Katarzyna C. Pituch Breakdown of academic impact, for papers by Sadhak Sengupta Breakdown of academic impact, for papers by Lukas Bunse Breakdown of academic impact, for papers by Stacy A. Decker Breakdown of academic impact, for papers by Yuedi Wang Breakdown of academic impact, for papers by Hikmat Assi Breakdown of academic impact, for papers by Nasser K. Yaghi Breakdown of academic impact, for papers by Roeltje R. Maas Breakdown of academic impact, for papers by Haipeng Tao
Rankless by CCL
2026